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Abstract
Background: Coping with cancer and the oncologist–patient relationship
can vary depending on the patient’s age. Our aim is to examine and com-
pare young and elderly adults with non-metastatic, resected cancer.
Methods: Two groups of patients were selected, young (< 40 years) and
elderly (> 70) with a diagnosis of non-metastatic, resected cancer requiring
adjuvant chemotherapy from a pre-exiting, national database (NEOCOPING
Study). Epidemiological variables were collected and subjects’ emotional
responses, perceptions of the physician–patient relationship, support net-
work, fears, and regret about the decision to receive chemotherapy were
assessed with questionnaires validated in previous studies: Mini-Mental
Adjustment to Cancer, Brief Summary Inventory (18 items), European Orga-
nization for the Research and Treatment of Cancer Quality of Life
Questionnaire-C30, Shared Decision-Making Questionnaire-Physician’s ver-
sion, Shared Decision-Making Questionnaire-Patient’s version, and
Informed Risk (physician and patient versions).
Results: Data from 46 young and 46 elderly participants were collected.
The most common neoplasms in both groups were breast (50%) and colo-
rectal (22%). The younger adults had a higher level of education and were
actively employed (72% vs. 7%). The leading coping strategy in the younger
cohort was hope, and resignation among the elderly. Young adults sought
more social support and the impact of diagnosis was more negative for
them than for older individuals. No signiﬁcant differences were detected in
quality of life; both age groups demanded more time at their ﬁrst visit with
the doctor, while the older group exhibited greater satisfaction with shared
decision-making. At the end of adjuvant chemotherapy, neither age group
regretted their decision to receive said treatment.
Conclusion: Higher levels of education, greater demands of the labour mar-
ket, and the advent of the age of information have entailed drastic changes
in the physician–patient relationship paradigm. This is especially true in the
younger cancer patient population, who require more information and active
participation in decision-making, can display more anxiety about their diag-
nosis, but also greater capacity to ﬁght.
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INTRODUCTION
Cancer is a disease that affects all age groups and
treatment and information is dispensed in a similar
fashion, despite the characteristics of each group
that can considerably impact the physician–patient
relationship.1 The young adults of today have grown
up in the age of information, with immediate access
to medical terms on the Internet, and ample knowl-
edge of their right to information and autonomy as
patients.2 Among these individuals, increased knowl-
edge about cancer may lessen their fears and uncer-
tainties regarding their diagnosis.3 The elderly, in
contrast, grew up at a time when medicine was prac-
tised paternalistically, without taking patients’ opin-
ions into account when prescribing treatment,
expecting them only to comply.
Recent years have seen attempts to delve into
coping and the different needs each generational
group poses in the light of cancer. Thus, several difﬁ-
culties have become apparent in each age group,
such as the lack of speciﬁc, validated questionnaires,
the inﬂuence of multiple bio-psychosocial variables
that modulate coping, and the need to educate and
raise awareness among healthcare professionals with
a high burden of care about the importance of
exploring patients’ expectations and adapt our dis-
course/message to the individual’s age.4
In the case of young adults, cancer appears at a
time in which they are undertaking their life plans,
for their professional, social, and family lives. The
diagnosis of a neoplasm disrupts these plans and
can lead to social isolation, loss of self-esteem,
frustration, lack of control, behavioural changes,
and resentment.3 The literature indicates that the
emotional impact of suffering cancer is greater
among young adults than the elderly, albeit the lat-
ter express their fears less, tend to repress their
emotions more, and adjust through passive
resignation.5
Previous studies reveal younger, previously
healthy, independent individuals ﬁnd it more difﬁcult
to assume the role of ‘patient, analyzing’ which is
manifested as a greater tendency toward discontent
with the care given, as well as a greater need to be
informed and actively participate in decision-mak-
ing.1 These ﬁndings indicate that the appropriate
information for this age must be provided early in the
course of illness, to allay their concerns and fears
surrounding how side effects might affect their life
and regarding their future prognosis.3
Therefore, this study has been designed with the
aim of analyzing coping with non-metastatic cancer
among younger adults versus elderly patients, the
changes that undergoing surgery followed by adju-
vant chemotherapy entail, and the needs and percep-
tion of shared decision-making between the
oncologist and patients in these age groups.
METHODS
Study design and patients
A cross-sectional, multi-centre, prospective, non-
interventionist study, NEOCOPING, was conducted
from July 2015 to March 2017 in 15 medical oncology
departments throughout Spain. Eligible patients con-
sisted of younger (≤ 40 years) and elderly (> 70 years)
cancer patients with complete, curative resection of
non-metastatic cancer treated with adjuvant chemo-
therapy. Individuals with dementia or any other serious
mental illness preventing them from understanding the
survey were excluded. The study was approved by
the Clinical Research Ethics Committee of each centre
and all participants provided written, signed, informed
consent. Each survey contained written instructions
and clearly speciﬁed that completing the form was
both voluntary and conﬁdential and would not affect
their care in any way. Subjects completed the ques-
tionnaires individually, with no time limit, without
supervision in their oncologist’s waiting-room. Self-
report scales were completed by the participants
(patients and oncologists) at the beginning of adjuvant
treatment.
Measures
Demographic and clinical characteristics (age; gen-
der, marital status; educational level; occupational
sector; tumour site and stage, and time since diagno-
sis) were collected for statistical purposes.
Mini-Mental Adjustment to Cancer
The Mini-Mental Adjustment to Cancer (Mini-MAC)1
scale is one of the most widely used instruments to
measure coping responses in individuals with cancer.
The 29-item mini-MAC is a reﬁnement of the original
MAC scale, and its brevity allows it to be included
within a battery of measures or used in clinical set-
tings. The Spanish version of the Mini-MAC by
R. Hernández et al.
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Costa-Requena and Gil was used.6 The mini-MAC
examines ﬁve cognitive coping responses:
helplessness-hopelessness (e.g., ‘I feel like giving
up’), anxious preoccupation (e.g., ‘I am apprehen-
sive’), cognitive avoidance (e.g., ‘Not thinking about it
helps me cope’), fatalism (e.g., ‘At the moment I take
one day at a time’), and ﬁghting spirit (e.g., ‘I see my
illness as a challenge’). The numerous studies that
have evaluated the mini-MAC’s psychometric proper-
ties have corroborated the reliability of all ﬁve sub-
scales.1,7 Nevertheless, studies have also proposed
that some of the subscales can be combined to com-
prise more general coping subscales. Anagnostopou-
los et al.3 proposed the ‘adaptive’ (ﬁghting spirit,
cognitive avoidance, and fatalism) and ‘maladaptive’
(helplessness-hopelessness and anxious preoccupa-
tion) subscales. Test–retest reliability ranged from
0.62 to 0.99; Cronbach’s alpha varied between 0.78
to 0.93.4
Multidimensional Scale of Perceived Social
Support
The Multidimensional Scale of Perceived Social Sup-
port (MSPSS) is a questionnaire that gauges social
support8 and consists of 12 items related to three
sources of social support: family, friends, and signiﬁ-
cant other. We used the validated Spanish version.9
Responses are furnished from 1 (very strongly dis-
agree) to 7 (very strongly agree). The MSPSS is
widely used in clinical and non-clinical samples and
has proven reliability and validity.10
Brief Symptom Inventory
The Brief Symptom Inventory-18 (BSI-18)11 contains
18 items covering three dimensions (somatisation,
depression, and anxiety). We used the validated
Spanish version.12 However, the Global Severity
Index (GSI) is the sum of the BSI-18 and summarises
the respondent’s overall emotional adjustment and
psychological distress. Participants answer how they
felt over the last 7 days; each item is rated on a ﬁve-
point Likert scale from 0 (not at all) to 4 (extremely).
The test–retest reliability ranged from 0.78 to 0.90.
Cronbach’s alpha ranged from 0.81 to 0.90.11
EORTC QLQ-C30
The European Organization for the Research and
Treatment of Cancer Quality of Life Questionnaire-C30
(EORTC QLQ-C30) is extensively used in Europe and
has well-established validity.13 It is a modular ques-
tionnaire consisting of a core questionnaire (EORTC
QLQ-C30) and additional diagnosis-speciﬁc mod-
ules.14 The Spanish version of EORTC QLQ-C30 pre-
sented by the EORTC was used for data collection. A
sample can be downloaded at the following URL:
http://groups.eortc.be/qol/eortc-qlq-c30. Patients
must rank each item from 1 (not at all) to 4 (very
much). The 30 items of the EORTC QLQ-C30 can be
summarised in ﬁve functioning scales, ‘Physical Func-
tioning’, ‘Role Functioning’, ‘Emotional Functioning’,
‘Social Functioning’ and ‘Cognitive Functioning’
(0, minimum quality of life (QOL); 100, maximum QOL)
and nine symptom scales, for example ‘Pain’, ‘Dys-
pnoea’, ‘Insomnia, ‘Appetite Loss’ and ‘Diarrhoea’
(0, no symptoms; 100, severe symptoms).
Shared Decision-Making Questionnaire-
Physician’s version
The Shared Decision-Making Questionnaire-Physi-
cian’s version (SDM-Q-Doc) appraises the physi-
cian’s opinion as to the degree to which they follow
SDM with their patients.15 The instrument comprises
nine items, each one describing one step of the pro-
cess; for instance, ‘My patient and I thoroughly
weighed the different treatment options’. We used
the validated Spanish version.16 Items are scored
0–5 on a six-point Likert scale as ‘completely dis-
agree’ (0) to ‘completely agree’ (5). The total raw
score of 0–45 is the sum of all items. To standardise
this raw summary score, the authors recommend
using linear transformation to obtain a scale from
0 to 100 (raw score multiplied by 20/9), on which zero
indicates the lowest level of perceived SDM. The
SDM-Q-Doc exhibits good internal consistency and
reliability in German (α = 0.88).17
Shared Decision-Making Questionnaire-Patient’s
version
The Shared Decision-Making Questionnaire-Patient’s
version (SDM-Q-9) is a brief, valid, reliable survey
that evaluates the SDM process from the patient’s
perspective.18 It was adapted and validated in Span-
ish by De las Cuevas et al.19 and subsequently vali-
dated patients with cancer.20 It was developed to
assess how involved patients feel in the decision-
making process. Items are scored 0–5 on a six-point
Coping strategies in cancer patients
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Likert scale ranging from ‘completely disagree’ (0) to
‘completely agree’ (5). A total raw score of 0–45 is
possible. Multiplication of the raw score by 20 pro-
vides a forced score (transformed), ranging from 0 to
100, where zero indicates the lowest possible level of
SDM and 100 indicates the highest. SDM-Q-9
reveals a high Cronbach alpha in Spanish (0.88)
patients with cancer.20
The Informed Risk (RI) physician and patient ver-
sion16 is a ﬁve-item scale created to ascertain
patients’ and physicians’ degrees of satisfaction with
the information provided about the disease, risk of
recurrence, treatment side effects, and time dedi-
cated to informing the patient.16 The items were
scored from zero to 10; the higher the score, the
greater the physician’s satisfaction with the informa-
tion provided and time dedicated.
Statistical analyses
Descriptive statistics were used to summarize demo-
graphic data and survey responses. Absolute frequen-
cies were presented for categorical data and means
and standard deviations (SD) for quantitative data.
Additional descriptive analyses were performed group-
ing patients by age. We conducted bivariate chi-square
and t-tests to assess differences in sociodemographic,
clinical, and psychological characteristics between
younger vs. older cancer patients. Univariate Analysis
of Variance (ANOVA) was used. Statistics were gener-
ated with a standard statistical package IBM SPSS Sta-
tistics for Windows, version 23.0 (IBM Corp., Armonk,
N.Y., USA).
RESULTS
At the time of data cut-off (June 2017), the study
included 92 patients, 46 young adults (14%) (18 in
stage III) and 46 older cancer patients (16 in stage III).
Twenty-four medical oncologists from 14 Spanish hos-
pitals participated in this study; 73.1% were women;
mean ages were 36.8 years (SD = 6.9, range 29–59),
and 12.9 years of experience (SD = 7.5, range 4–38).
No signiﬁcant differences were found between male
and female oncologists with respect to age (t = 1.092,
P = 0.0278) or years of experience (t = 1.295,
P = 0.206). Most were super-specialists (86.9%) and
worked at a public teaching hospital (60.2%).
Baseline characteristics are presented in Table 1.
Mean patient age was 36.3 and 72.3 years for
younger and older patients, respectively. Both groups
contained more women than men (67% vs. 33%),
with a similar percentage of married individuals (80%
among younger and 69% in older participants). How-
ever, both groups exhibited different levels of studies;
young adults had more academic education,
χ2 = 4.073, P = 0.044.
With respect to clinical variables, the most com-
mon cancer in both groups was breast (50%), fol-
lowed by colon (22%). Elderly patients received a
single drug treatment regime more than young adults
who received two or more drugs, (72% vs. 50%),
χ2 = 5.580, P = 0.018. No signiﬁcant differences
between groups were detected in stage of disease at
the time of diagnosis, time between onset of symp-
toms and diagnosis, or risk of relapse.
Psychological adaptation to cancer
Differences in psychological adaptation by cancer
type are reported in Table 2.
Coping with cancer and social support
The most usual coping strategies were ﬁghting spirit
and hopelessness; by and large, members of both
groups displayed adaptive coping strategies. Young
adults with cancer showed more hope than older
patients (F1,91 = 5.180, P = 0.025, Cohen’s
d = 0.4476), whereas the latter revealed more strate-
gies of resignation than the former (F1,91 = 4.754,
P = 0.032, Cohen’s d = 0.461). As for Support Social,
young adults sought more support in their social sur-
roundings than older patients (F1,91 = 4.295, P = 0.041,
Cohen’s d = 0.467).
Cancer diagnosis and QOL
The impact of the diagnosis of cancer was more neg-
ative among younger subjects than older ones
(F1,91 = 4.272, P = 0.042, Cohen’s d = 0.428). No
signiﬁcant differences were found in QOL between
age groups on any of the subscales.
Shared decision-making and quality of care
Patients’ and oncologists’ evaluations of shared
decision-making were similar in both age groups;
likewise, no signiﬁcant differences were detected in
the assessment of both clinicians and participants of
the information provided by the physician or in the
time dedicated to the visit. Once adjuvant
R. Hernández et al.
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chemotherapy was completed, neither group regret-
ted their decision to undergo it.
Nevertheless, if we compare doctors’ and patients’
perceptions of shared decision-making (see Table 3),
both were satisﬁed, albeit physicians (t = −3.453,
P < 0.001) and older patients (t = −3.191, P < 0.001)
scored it better. Physicians were more satisﬁed than
their patients with the information they had given
regarding informed risk in both young adults
(t = −14.071, P < 0.001) and older individuals
(t = −10.525, P < 0.001).
Even though 80% of the doctors indicated that
they had dedicated an average of 45 min to the visit,
both younger and older participants felt they had
needed more time (t = −3.511, P < 0.001,
t = −3.186, P = 0.003, respectively).
DISCUSSION
Young adult and elderly cancer sufferers are two, tra-
ditionally underrepresented age groups in clinical
trials and epidemiological studies. This void in the lit-
erature is the main motivation in conducting this
analysis which compares coping in these two groups
of subjects with surgically treated, non-metastatic
cancer and examines the need for an approach
suited to their speciﬁc circumstances and to the
physical, emotional, and social consequences of
overcoming cancer in each age group.
Insofar as sociocultural surroundings are con-
cerned, as expected, the young adult patients have
more academic education and tend to be employed,
whereas the elderly are retired or unemployed.
Among the former, the stress that follows diagnosis
is compounded by the economic challenges posed
by the costs associated with integral care for their
disease, as well as the possible loss of their ability to
work while receiving adjuvant chemotherapy. This is
why it is important, particularly in young adults, to
assess professional aspirations and the need to
remain active to conserve their lifestyle and employ-
ment once they have ﬁnished treatment, and to




(N = 46) t/χ2 P
Gender: n (%)
Women 15 (33) 15 (33) 0.000 1.000
Men 31 (67) 31 (67)
Age, years, mean (SD) 36.3 (4.4) 72.3 (7.4) −28.036 0.001
Marital status: n (%)
Married/ partnered 37 (80) 32 (69) 1.449 0.229
Others 9 (20) 14 (31)
Educational level: n (%)†
Primary 30 (65) 39 (91) 4.073 0.044
High school or above 15 (35) 7 (9)
Working: n (%)
Active 33 (72) 3 (7) 41.071 0.001
Retired 13 (28) 43 (93)
Localisation of cancer: n (%)
Colon 10 (22) 10 (22) 0.001 1.000
Breast 23 (50) 23 (50)
Others 13 (28) 13 (28)
Stage: n (%)
I–II 28 (61) 30 (65) 0.187 0.666
III 18 (39) 16 (35)
Time since diagnosis: days (SD) 124.1 (204) 63.1 (54.4) 1.688 0.099
Type of treatment: n (%)
CT + surgery 24 (52) 27 (59) 0.396 0.529
CT + surgery + RT 22 (48) 19 (41)
Chemotherapy treatment: n (%) 5.580 0.018
Single drug 23 (50) 33 (72)
Combination of drugs 23 (50) 13 (28)
Risk of relapse 41.8 (18.7) 45.7 (25.2) −0.821 0.414
Bold values indicate the signiﬁcant at 5% level. †Due to a patient not answering this question, the n does not add up to 46. CT, chemotherapy; RT,
radiotherapy,
Coping strategies in cancer patients
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provide social support to adapt their job to their abili-
ties and limitations while they undergo treatment and
gradually readjust once therapy has concluded.
Moreover, treatment for cancer tends to be more
aggressive in younger patients; therefore, sequelae
are potentially greater, longer lasting and more likely
to interfere with their job and social interactions.21
As for tumour characteristics, no signiﬁcant differ-
ences were encountered regarding the stage of
disease, time between onset of symptoms and diag-
nosis, type of treatment, or risk of relapse. Therefore,
the differences between age groups in coping with
their cancer and perception of their relationship with
the oncologist may be due more to sociodemo-
graphic factors than speciﬁc factors stemming from
the disease itself.
Our study has evinced that young adults are
harder hit by the impact of cancer, exhibiting more






M (SD) F P Effect size
Coping with cancer (Mini-MAC)
Fight 77.5 (20.7) 73.1 (18.8) 1.106 0.296 ---
Hopelessness 83.7 (16.8) 75.1 (19.3) 5.180 0.025 0.476
Anxiety 47.1 (22.9) 45.2 (25.9) 0.126 0.724 ---
Resignation 60.2 (22.0) 69.7 (19.2) 4.754 0.032 0.461
Avoidance 55.1 (29.8) 54.7 (23.1) 0.004 0.948 ---
Social support (MSPSS)
Family 25.3 (3.2) 25.0 (3.7) 0.597 0.223 ---
Friends 24.1 (4.5) 22.5 (4.7) 2.751 0.101 ---
Social 26.1 (3.3) 24.3 (4.4) 4.295 0.041 0.467
Psychological distress (BSI)† 67.2 (6.9) 64.2 (7.1) 4.272 0.042 0.428
Quality of life
Functional scale 41.4 (11.2) 39.6 (11.7) 0.617 0.434 ---
Symptom scale 38.8 (10.9) 35.8 (12.5) 0.257 0.613 ---
Health status 73.3 (17.2) 74.3 (16.1) 0.097 0.757 ---
Quality of life 58.6 (5.7) 58.4 (5.8) 0.567 0.453 ---
Shared decision-making
Physician’s version 92.5 (8.3) 89.1 (10.0) 2.882 0.093 ---
Patient’s version 80.3 (19.3) 75.2 (20.7) 1.436 0.234 ---
Informed risk (physician)
Satisfaction with information 98.2 (6.4) 97.4 (29.3) 0.036 0.850 ---
Time 90.6 (29.3) 89.7 (30.7) 0.910 0.343 ---
Informed risk (patient)
Satisfaction with information 67.5 (12.1) 67.0 (14.1) 0.170 0.682 ---
Time 72.2 (20.3) 67.3 (23.2) 0.021 0.405 ---
Regret 12.2 (13.1) 19.7 (23.3) 1.450 0.236 ---
Bold values indicate the signiﬁcant at 5% level. †T-score. M, mean; Mini-MAC, Mini-Mental Adjustment to Cancer; MSPSS, Multidimensional Scale of Per-
ceived Social Support; BSI, Brief Symptom Inventory




M (SD) t P
Young patients
Shared decision-making 92.5 (8.3) 81.4 (18.6) −3.453 0.001
Informed risk
Satisfaction with information 98.2 (12.4) 67.6 (12.4) −14.071 0.001
Time 90.6 (29.3) 71.8 (20.9) −3.511 0.001
Older patients
Shared decision-making 89.1 (10.0) 76.5 (21.1) −3.191 0.003
Informed risk
Satisfaction with Information 97.2 (11.4) 66.8 (14.2) −10.525 0.001
Time 89.7 (30.7) 67.3 (25.1) −3.186 0.003
Bold values indicate the signiﬁcant at 5% level. M, Mean
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psychological stress than the elderly. Cancer forces
younger patients especially to reconsider many
aspects of their lives, changing plans and projects for
an indeﬁnite period of time, causing a loss of inde-
pendence, as well as other, secondary issues, such
as economic difﬁculties, changes in their appear-
ance, and work restrictions. This generates strong
feelings of frustration, isolation, sadness, anger, fury,
and hopelessness.5,10,17 In contrast, they also have
more psychological resources than the elderly to
ﬁght and cope with this period, turning resentment
into a feeling of confrontation and ﬁght, accepting
their reality, and conveying optimism.17
In our study, the most widely used coping strategy
among young adults was hope, whereas seniors used
more resignation. This ties in with the fact that young
adults typically demand more information about treat-
ment strategies and prognosis, which would engender
a ﬁghting spirit. Our results are backed by those of a
study carried out in 380 oncological patients at hospi-
tals in northwest England where the younger popula-
tion expressed a greater need for information about
their illness, as well as more emotional, identity, and
spiritual concerns than the older ones.15 Conversely,
other studies have revealed that the elderly experi-
ence less psychological distress after being diag-
nosed with cancer, enabling them to adapt better to
it.22,23 One study performed in Newcastle among
adults who had survived childhood cancer showed
that their experience with the disease had affected
their overall perspectives, giving them a greater
appreciation for life and other people, since they had
realised that life can be both short and uncertain.24
Rosenberg et al. concluded that the resilience of
young people recently diagnosed with cancer is
directly associated with their personal resources and
learned abilities: stress management, goal-setting,
positive reframing, searching for beneﬁts, social sup-
port, and maintaining relationships with relatives and
peers.25 One recent study on depression in cancer
survivors found no difference in the rates of clinically
relevant depression between the younger and older
adult cohorts, although there was a trend toward
more depression among the younger patients.
Women and Hispanic/Latin patients, regardless of
age, revealed a higher prevalence of depression.26
In our series, young adults sought more support
from their peers. Some works have reported that
young adults need continuous and greater support
than older ones, not only from healthcare profes-
sionals, but also from family and from their social
group and friends.27,28 It will only be possible to
maintain this support network when the patient is
able to have an active, positive attitude in this new
situation in their life with the maximum support of
professionals, relatives, friends, and society who
must understand the greater necessity for care and
support because of their diagnosis of cancer.3,29,30
In recent years, we have witnessed a paradigm shift
in the physician–patient relationship, from a ‘paternal-
istic’ attitude, in which the clinician determined com-
plementary testing and the treatment plan, toward an
approach in which the specialist must provide all the
information available so that the patient can decide
what the best choice is based on their right to auton-
omy.1,7 Although differences across countries do
exist, a poll conducted in eight European countries
revealed that most patients wanted to receive more
information and participate more actively in the
decision-making process. Nevertheless, their expecta-
tions surrounding said participation differed signiﬁ-
cantly from one country to the next; for instance, in
Spain and Poland, the participants preferred a more
paternalistic model than in Switzerland or Germany.31
Numerous studies have demonstrated that shared
decision-making enhances physician–patient rapport,
response to treatment, as well as the patient’s QOL,
especially within a context like cancer.4 Nevertheless,
comparing the opinions of doctors and patients in our
study, physicians are satisﬁed with shared decision-
making, with the information they provide, and the
time they dedicate to the subject. Patients do not
agree, as both younger and older adults would like to
participate more in making decisions and have more
information and time, even when in most cases (80%),
the visit lasted more than 45 min. A more qualitative
type of study would be needed to analyze these differ-
ences, as well as whether the dissatisfaction was due
to the lack of information received or to the way in
which it was provided.
Studies performed in primary care have revealed
the fact that many patients do not ask all the ques-
tions they would have wanted to, expressing the
need for a longer appointment.32,33 This can be due
to the idea from the studies by Ley et al.32 according
to which the patient would forget 30–50% of the
information given because of the tremendous impact
of the diagnosis of cancer, treatment complexity, and
Coping strategies in cancer patients
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uncertainty around being cured. On the other hand,
understanding how much the patient wants to know
and how to communicate best with each one based
on age and other biopsychosocial variables are other
aspects to be taken into account.
This study has several limitations. The ﬁrst is that,
although higher than in other studies published and
with a large total sample size, the number of young
adult patients is limited. The second is that these are
results from subjects in a single country. The third is
that the information was obtained at a given time, dur-
ing the visit to medical oncology to initiate adjuvant
chemotherapy, without being able to ascertain time-
dependent, intra-individual variability. An additional
limitation has to do with the administration of a long
protocol, completed in the physician’s waiting room,
and that may have contributed to respondent’s fatigue
and abandonment of the questionnaire,31 particularly
in older patients who need more time to answer the
questions. In order to decrease this bias in future
studies, the questions could be read to those patients
who need it or the protocol could be administered in
two stages; alternatively, they could be allowed to ﬁll it
in at home.
In short, young adults with non-advanced, resected
cancer beginning adjuvant chemotherapy exhibit
greater psychological distress than the elderly, as well
as hope-based coping, whereas older patients display
an attitude of resignation. Both groups would like to
participate more in shared decision-making regarding
the advisability of adjuvant chemotherapy, receive
more information, and have more time for it.
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